Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-16-100857
Filing Date
2016-05-11
Accepted
2016-05-11 16:27:34
Documents
79
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v435952_10q.htm 10-Q 311349
2 EXHIBIT 31.1 v435952_ex31-1.htm EX-31.1 8454
3 EXHIBIT 31.2 v435952_ex31-2.htm EX-31.2 8204
4 EXHIBIT 32.1 v435952_ex32-1.htm EX-32.1 3877
5 EXHIBIT 32.2 v435952_ex32-2.htm EX-32.2 3857
  Complete submission text file 0001144204-16-100857.txt   4468377

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT xtnt-20160331.xml EX-101.INS 916507
7 XBRL TAXONOMY EXTENSION SCHEMA xtnt-20160331.xsd EX-101.SCH 50353
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE xtnt-20160331_cal.xml EX-101.CAL 54741
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xtnt-20160331_def.xml EX-101.DEF 341960
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE xtnt-20160331_lab.xml EX-101.LAB 398179
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xtnt-20160331_pre.xml EX-101.PRE 387326
Mailing Address 664 CRUISER LANE BELGRADE MT 59714
Business Address 664 CRUISER LANE BELGRADE MT 59714 406-388-0480
Xtant Medical Holdings, Inc. (Filer) CIK: 0001453593 (see all company filings)

EIN.: 205313323 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34951 | Film No.: 161640236
SIC: 2836 Biological Products, (No Diagnostic Substances)